ctrl K

Watchlist Price Alert

Ambrx Biopharma Inc. (AMAM)

NYSE: AMAM · Real-Time Price · USD

28.00

0.02 (0.07%)

At close: Mar 06, 2024, 9:00 PM

Ambrx Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	55.61M	170.06M	90.46M	15.49M
Short-Term Investments	28.87M	n/a	n/a	n/a
Long-Term Investments	16.79M	n/a	n/a	n/a
Other Long-Term Assets	339K	530K	624K	319K
Receivables	2.05M	1.34M	982K	1.39M
Inventory	3.73M	5.17M	1.44M	1.13M
Other Current Assets	319K	230K	191K	146K
Total Current Assets	90.58M	176.81M	93.08M	18.16M
Property-Plant & Equipment	14.01M	15.72M	3.49M	4.97M
Goodwill & Intangibles	25.25M	35.96M	36.83M	38.28M
Total Long-Term Assets	56.39M	52.21M	40.94M	43.57M
Total Assets	146.98M	229.02M	134.02M	61.73M
Account Payables	3.21M	5.27M	2.82M	5.39M
Deferred Revenue	407K	4.27M	6.47M	4.21M
Short-Term Debt	1.73M	915K	1.59M	1.45M
Other Current Liabilities	11.31M	14.13M	2.38M	3.88M
Total Current Liabilities	16.66M	24.58M	13.26M	14.94M
Long-Term Debt	10.24M	12.21M	1.6M	3.19M
Other Long-Term Liabilities	n/a	n/a	253.17M	n/a
Total Long-Term Liabilities	12.47M	14.47M	258.91M	10.8M
Total Liabilities	29.13M	39.05M	272.17M	25.74M
Total Debt	11.98M	13.13M	3.19M	4.65M
Common Stock	27K	27K	n/a	14K
Retained Earnings	-291.63M	-213.63M	-145.55M	-129.01M
Comprehensive Income	-1.3M	-790K	-686K	-843K
Shareholders Equity	117.85M	189.97M	-139.43M	33.42M
Total Investments	45.67M	n/a	n/a	n/a